A pharmacy rejects a prescription claim, and the patient calls the practice for an update. Staff often cannot say when an answer will arrive, because deadlines differ by payer and program.
So how long does prior authorization take for medication, and which deadline applies? Medicare Part D, Medicaid, and commercial plans each follow different rules, and one federal rule excludes drugs entirely.
This guide covers typical turnaround times, common delay causes, task ownership, and tracking methods for practice teams.
The AMA’s 2025 survey found that prior authorization consumes about 13 hours of physician and staff time weekly.
Clear deadlines and an owner for each request help limit avoidable waiting. Accurate expectations also help staff set realistic follow-up dates with patients and prescribers.
Key Takeaways
- Typical decisions arrive within 24 to 72 hours when documentation is complete.
- Medicare Part D sets 72-hour standard and 24-hour expedited coverage determination deadlines.
- CMS-0057-F’s seven-day and 72-hour deadlines apply to non-drug items and services only.
- Proposed CMS drug rules would add deadlines in 2027 but remain unfinalized.
How Long Does Prior Authorization Take For Medication By Payer?

The prior authorization timeline for medications depends on the covering program, the request urgency, and documentation completeness. The sections below separate typical timing from legal deadlines.
Medication prior authorizations typically take 24 to 72 hours once documentation is complete. Medicare Part D plans must decide standard requests within 72 hours and expedited requests within 24. Incomplete records, specialty drugs, and appeals can stretch the wait to weeks.
| Program | Deadline | Note |
| Medicare Part D | 72 hours standard, 24 hours expedited | Exceptions start at prescriber statement |
| CMS-0057-F payers | 7 days standard, 72 hours expedited | Excludes drugs |
| Medicaid outpatient drugs | 24 hours | State details vary |
| Fully insured commercial | Plan contract, state law | California: 72 hours, 24 urgent |
| Self-funded employer | Plan terms | State mandates generally exempt |
The applicable deadline depends on the program covering the drug, not the drug itself.
| Scope Note |
|---|
| Dental and veterinary prescription workflows may differ from these human medical rules. |
Typical Turnaround Range
Medication prior authorization turnaround time often falls between 24 and 72 hours when the request is complete.
Blue Shield of California, for example, states that its drug reviews typically take 24 to 72 hours. Specialty drugs and incomplete submissions often take longer.
GoodRx reports a range from a couple of days to a few weeks. That range is a payer-reported norm and not a universal legal deadline. Practices should check each payer’s published turnaround in the provider manual.
Medicare Part D Deadlines
The Medicare Part D coverage determination timeframe is 72 hours for standard requests and 24 hours for expedited requests. CMS publishes these limits in its Part D coverage determination and appeals flowchart.
Expedited review applies when the prescriber indicates that waiting could seriously harm the patient’s health.
For formulary and tiering exceptions, the clock starts when the plan receives the prescriber’s supporting statement. A first-level appeal, called a redetermination, takes up to 7 days for standard requests and 72 hours when expedited.
Why CMS-0057-F Excludes Drugs
CMS-0057-F sets prior authorization decision deadlines of 72 hours for expedited requests and seven calendar days for standard ones.
These deadlines took effect on January 1, 2026, for Medicare Advantage, Medicaid, CHIP, and certain other payers. The CMS-0057-F fact sheet states that the rule’s policies do not apply to prior authorization decisions for drugs.
A drug request therefore falls outside the seven-day and 72-hour deadlines. Staff should not cite those deadlines when following up on a prescription.
Commercial Plans And PBMs
Pharmacy benefit manager prior authorization is common, since many health plans delegate formulary management to a PBM. Turnaround for commercial drug coverage follows the plan contract, the provider manual, and applicable state law.
Staff should confirm which entity reviews the drug, because pharmacy and medical benefits can use separate processes. A request sent to the wrong reviewer may add days. The pharmacy’s rejection message often points to the PBM handling the claim.
State Law Deadlines
Some states set their own health insurance deadlines for prescription drug requests. California requires plans and insurers to respond within 72 hours for non-urgent requests and 24 hours for urgent ones. The California Medical Association summarizes this law, SB 282, on its website.
A step therapy exception request follows the same response times in California. State laws generally govern state-regulated plans, so self-funded employer plans may follow different rules. Staff should confirm the patient’s plan type before citing any state deadline.
Medicaid And CHIP Timelines
Medicaid programs already follow a 24-hour standard for covered outpatient drugs, based on federal requirements described by CMS. CMS has proposed aligning Medicaid managed care and CHIP drug deadlines with existing federal timeframes.
State Medicaid agencies publish their own submission channels, forms, and formulary criteria. Medicaid managed care plans may also run separate portals and forms. Staff should check the state program’s current provider bulletin before relying on any general figure.
Common Causes of Prior Authorization Delays
Delays in the prior authorization process for prescription drugs can stem from workflow gaps. The causes below follow a request from pharmacy rejection to final decision.
- Incomplete documentation such as missing chart notes, lab results, or prior therapy history can stall review.
- Step therapy gaps arise when payers require proof of earlier drug trials and the dates or outcomes are missing.
- A rejected insurance claim at the pharmacy must reach the prescriber before any request can begin.
- When a medication prior authorization is denied, the appeal process or a peer-to-peer review adds time.
The AMA survey also found that two in five physicians employ staff dedicated exclusively to prior authorization. It reports that 94 percent of physicians say the process contributes to physician burnout.
Who Handles What In Prior Authorization

Clear task ownership helps keep requests from stalling between the front desk, clinical team, and prescriber. Administrative and clinical duties differ, and the split matters for compliance.
Administrative staff can identify the plan, gather chart documentation, complete payer forms, submit requests, and log every contact. A healthcare virtual assistant can support these administrative steps under practice supervision when access is properly limited.
The prescriber, as the healthcare provider ordering the drug, supplies the clinical rationale and signs supporting statements. Medical necessity decisions and alternative therapy choices stay with licensed clinicians.
HIPAA does not require patient authorization for disclosures made for treatment or payment, according to HHS. Role-based access, access logs, and a business associate agreement with any outside vendor remain standard safeguards.
Safeguards for remote staff appear in this guide to HIPAA compliant virtual assistant practices.
How To Track And Escalate Pending Requests
A prior authorization tracking workflow gives every request a start date, a deadline, and an owner. The log below can be kept in the EHR, a practice management system, or a shared spreadsheet.
| Log field | Purpose |
| Date submitted | Starts follow-up timeline |
| Date complete | Marks when required items arrived |
| Payer deadline | Standard or expedited, per program |
| Decision and end date | Triggers renewal tracking |
Follow-up should begin at the payer deadline, or sooner if the patient is waiting on medication approval. If the deadline passes, staff confirm receipt, ask what is missing, and notify the prescriber.
An expedited prior authorization medication request depends on the prescriber’s statement that delay could harm the patient.
For denials, appeal steps begin with the payer’s stated denial reason and any peer-to-peer option. Approval end dates deserve their own reminder, since expired approvals force a new request.
ePA For Medications And Pending Rules

Electronic prior authorization for medications already exists in Medicare Part D, and federal proposals would extend it to more payers. Status matters because proposed rules do not create enforceable deadlines.
Since 2022, CMS has required Part D plans to use the NCPDP SCRIPT standard for electronic prior authorization. CMS-0062-P, a proposed rule released in April 2026, would extend electronic requests and decision deadlines to drugs for certain payers.
Proposed compliance dates would begin on October 1, 2027, if the rule is finalized.
CMS still lists the rule as proposed, and its public comment period closed on June 15, 2026. About 60 insurers pledged in June 2025 to simplify prior authorization, but only 33 percent of physicians expect meaningful change.
Healthcare providers can prepare by asking their EHR vendor and major payers about ePA support.
Frequently Asked Questions (FAQs)
How long does a prior authorization take for specialty medications?
No fixed deadline applies to specialty drugs alone. The program’s deadline governs, and specialty requests often need additional clinical documentation, which can extend review.
Does the CMS seven-day rule apply to medication prior authorizations?
No, CMS-0057-F excludes drugs, so Part D, Medicaid, state, and plan-specific deadlines apply instead. Proposed rule CMS-0062-P would extend similar requirements to drugs if finalized.
How long does a medication prior authorization approval last?
Approval periods vary by plan and drug, so the approval notice shows the end date. Staff can track that date to start renewals before therapy is interrupted.
What should staff do when a request misses its deadline?
Confirm the payer received a complete request, document the contact, and notify the prescriber. The prescriber can then consider an expedited request, peer-to-peer review, or alternative therapy.
Final Thoughts
How long does prior authorization take for medication? The answer depends on the program, the urgency, and request completeness.
Medicare Part D and Medicaid follow defined deadlines, while commercial timelines depend on contracts and state law.
Practices that log submission dates, assign owners, and set follow-up dates give staff a reliable way to catch stalled requests. Rules for drugs are still changing, so periodic checks of CMS guidance remain worthwhile for every practice.
References
- American Medical Association. AMA survey: Prior authorization reform pledge falls short with physicians
- Centers for Medicare & Medicaid Services. Medicare Prescription Drug (Part D) Coverage Determination and Appeals Process flowchart
- Centers for Medicare & Medicaid Services. CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) fact sheet
- Centers for Medicare & Medicaid Services. 2026 CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule fact sheet
- Centers for Medicare & Medicaid Services. CMS-0062-P proposed rule page
- Health Affairs Forefront. Understanding CMS’s Proposed Rule Regarding Prior Authorization For Drugs
- U.S. Department of Health and Human Services. Treatment, payment, and health care operations disclosures
- California Medical Association. Updates to prior authorization form for prescription medications and new timelines for response
- National Conference of State Legislatures. State-Regulated Health Plans vs. ERISA Plans
- Blue Shield of California. Drug prior authorizations
- GoodRx. Prior Authorization: What You Need to Know



